A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations

Clinical trial NCT01131429 · UNKNOWN

Trial details

NCT number: NCT01131429
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Lung Carcinoma, Non-Small Cell Lung Drug Therapy Genes, EGFR

Start date: 2010-06-01
Primary completion: 2013-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.